BYSI Projected Dividend Yield
Ord/BeyondSpring Inc ( NASDAQ : BYSI )BeyondSpring is a holding company. Through its subsidiaries, Co. is principally engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. Co.'s primary asset, Plinabulinv, a Selective Immunomodulating Microtubule-Binding Agent, is being developed as a pipeline in a drug in various cancer indications. Co. is also developing three small molecule immune agents in preclinical stages. In addition, Co.'s subsidiary, SEED Therapeutics Inc., is utilizing a certain Targeted Protein Degradation platform, or molecular glue technology, to develop therapeutic agents from internal research and development efforts and from collaboration. 20 YEAR PERFORMANCE RESULTS |
BYSI Dividend History Detail BYSI Dividend News BYSI Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |